|
EUCOPE (www.eucope.org) was founded in 2008 in Brussels and promotes companies and associations active in research, development, production and distribution of pharmaceutical products and enhances their scientific, technical, economic and legal objectives. Via the member associations (the German Pharmaceutical Industry Association (BPI), the Ethical Medicines Industry Group (EMIG) of the UK, the Swedish Associations SwedenBio and IML as well as BioDeutschland) EUCOPE represents more than 900 mid-sized innovative member companies, many of them SMEs. In addition, many innovative companies from Sweden, UK, France, Bulgaria, Italy, Greece, Germany, the Netherlands and Austria are represented on the Board of the association. EUCOPE membership includes innovative family owned companies such as Sigma-Tau, Ferring, B.Braun, Vianex or Bionorica as well as innovative companies active in the field of rare diseases such as Alexion, Celgene, Otsuka or Grifols (http://www.eucope.org/en/about-us/members/ / http://www.eucope.org/en/positions/). ==Structure== * President of the Association: Jan G. Smith, (ABIGO Medial AB ), Sweden. * Vice-President: Dr. Bernd Wegener, (B.R.A.H.M.S AG ), Germany. * Vice-President: Stefano Bonani, SEGIX ITALIA srl, Italy * Treasurer: Dr. Sigurd Pütter, (Arzneimittel Pütter GmbH & Co. KG ), Germany * Secretary General: Dr. Alexander Natz 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「EUCOPE」の詳細全文を読む スポンサード リンク
|